The role for vitamin B-6 as treatment for depression: A systematic review

Family Practice

Volumn 22, Issue 5, 2005, Pages 532-537

  Williams, Anna Leila ^a   Cotter, Anne ^b   Sabina, Alyse ^a   Girard, Christine ^a,c   Goodman, Jonathan ^a,d   Katz, David L ^a  

^a Yale Griffin Prevention Research Center   (United States)

^b Associates in Rehabilitative Medicine   (United States)

^c Southwest College Naturopathic Med   (United States)

^d Solutions for Better Health   (United States)

Author keywords

Alternative medicine; Complementary therapies; Depression; Dietary supplement; Vitamin B 6

Indexed keywords

PLACEBO; PYRIDOXINE;

ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; COMORBIDITY; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; DEPRESSION; HUMAN; MEDLINE; OUTCOMES RESEARCH; PSYCINFO; PUBLICATION; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

DEPRESSION; HUMANS; RANDOMIZED CONTROLLED TRIALS; VITAMIN B 6;

EID: 26444467744     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmi040     Document Type: Article

References (30)

1. Murray O, Lopez AD. Global Mortality, disability, the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442.
2. Goldman L, Nielsen N, Champion H. Awareness, Diagnosis, and Treatment of Depression. J Gen Intern Med 1999; 14: 569-580.
3. Burt V, Stein K. Epidemiology of Depression throughout the female life cycle. J Clin Psychiatry 2002; 63 (suppl 7): 9-15.
4. Greenburg PE, Stiglin LE, Finklestein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405-418.
5. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. J Affect Disord 2000; 60: 121-130.
6. NCCAM. What is complementary and alternative medicine? Available at: http://nccam.nih.gov/health/whatiscam/2004.
7. Eisenberg D, Davis R, Ettaer S, Appel S, Wilkey S, Van Rompay M et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. J Am Med Assoc 1998; 280: 1569-1575.
8. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay M et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 2001; 158: 289-294.
9. Ernst E, Rand JI, Stevinson C. Complementary therapies for depression: an overview. Arch Gen Psych 1998; 55: 1026-1032.
10. Godfrey PS, Toone BK, Carney MW et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336: 392-395.
11. Abou-Saleh MT, Coppen A. Serum and red blood cell folate in depression. Acta Psychiatr Scand 1989; 80: 78-82.
12. Katz DL, Williams A-L, Girard C, Goodman J, Comerford BP, Behrman A et al. The Evidence Base for Complementary and Alternative Medicine: Methods of Evidence Mapping with Application to CAM. Alternative Therapies in Health and Medicine 2003; 9: 22-30.
13. Cochrane Collaborative. The Cochrane Reviewers' Handbook 4.0 program. www.cochrane.org/cochrane/hbook.htm.
14. Bernstein AL. Vitamin B-6 in clinical neurology. Ann NY Acad Sci 1990; 585: 250-260.
15. Bender DA. Non-nutritional uses of vitamin B-6. Br J Nutr 1999; 81: 7-20.
16. Wyatt KM, Dimmock PW, Jones PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: Systematic review [see comments]. Br Med J 1999; 318: 1375-1381.
17. Mattes JA, Martin D. Pyridoxine in premenstrual depression. Hum Nutr Appl Nutr 1982; 36: 131-133.
18. Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B-6) and the premenstrual syndrome: A randomized crossover trial. J R Coll Gen Pract 1989; 39: 364-368.
19. Bell IR, Edman JS, Morrow FD, Marby DW, Perrone G, Kayne HL et al. Brief communication. Vitamin B1, B2, and B-6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction. J Am Coll Nutr 1992; 11: 159-163.
20. Adams PW, Rose DP, Folkard J, Wynn V, Seed M, Strong R. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. Lancet 1973; 1(7809): 899-904.
21. Reynolds RD, Styer DJ, Schlichting CL. Decreased vitamin B-6 status of submariners during prolonged patrol. Am J Clin Nutr 1988; 47: 463-469.
22. De Souza MC, Walker AF, Robinson PA, Bolland K. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B-6 for the relief of anxiety-related premenstrual symptoms: A randomized, double-blind, crossover study. J Womens Health Gend Based Med 2000; 9: 131-139.
23. Holsboen F, Benkert O, Meier L, Kreuz-Kersting A. Combined estradiol and vitamin B-6 treatment in women with major depression [letter]. Am J Psychiatry 1985; 142: 658.
24. Khan AU. Neurochemistry of Schizophrenia and Depression. Clovis, CA: A.J. Publisher; 1998.
25. Schilderkraut JJ. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 1965; 122: 509-522.
26. Janowsky DS, El-Yousef MK, Davis JM. A cholinergic adrenergic hypothesis of mania and depression. Lancet 1972; 2: 632-635.
27. Frackiewicz EJ, Shiovitz TM. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder. J Am Pharm Assoc 2001; 41: 437-447.
28. Caspar RF, Hearn MT. The effect of hysterectomy and bilateral oophorectomy on women with severe premenstrual syndrome. Am J Obstetric Gynecology 1990; 162: 105-109.
29. Casson P, Hahn PM, Van Vugt DA, Reid RL. Lasting response to ovariectomy i severe intractable permenstrual syndrome. Am J Obstetric Gynecology 1990; 162: 99-105.
30. Moline ML, Zendell SM. Evaluating and managing premenstrual syndrome. Medscape General Medicine 2000; 2. www.medscape.com/viewarticle/ 408913